# LFTD PARTNERS INC. (LIFD) · Edgar & Edgarette company card

> Lftd Partners (LIFD) saw revenue fall 1.1% in FY2025 to $37 million, operating margin 2.5% against a -3.8% median for pharmaceutical preparations, equity 65.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1391135 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/LIFD) · [JSON](https://www.pops4.com/boards/company/LIFD.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $37M |
| Revenue growth, 1 year | -1.1% |
| Revenue growth per year | 3.9% |
| Operating margin | 2.5% (prior year -2.1%) |
| Net margin | -67.3% |
| Operating cash flow | $1M |
| Capital spending | $121,639 |
| Free cash flow | $1M |
| Cash | $2M |
| Long-term debt | — |
| Total assets | $19M |
| Total equity | $13M |
| Equity ÷ assets | 65.5% |
| Return on equity | -196.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 1.02 (distress zone)
- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: Old boat · three warning signs · filed late annual report notice in the last 12 months; slow and jumpy: growing slower than its size class, with revenue that swings more; revenue is hard to predict: its 80% range is ±59%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $36.9M (FY2025). Experience: revenue down 1.1% on the year, up 3.9% a year over 4 years; operating margin 2.5%, up from -2.1%. Soundness: equity 65.5% of assets, return on equity -196.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $17.0M and $66.6M next year (method v4.1: its own 4-year record of growth weighed at 50% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $15.5M to $73.4M. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin 2.5% against a -3.8% median; growth -1.1% against 13.7%.

Range logged 2026-10-02, receipt 078141f76170b14e, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-04-01 ([filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000450/0001096906-26-000450-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-06-17 ([filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000966/0001096906-26-000966-index.htm))

## Recent filings

- 10-Q · filed 2026-11-13 · [filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626001745/0001096906-26-001745-index.htm)
- 8-K · filed 2026-10-01 · 1.02 Termination of a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626001491/0001096906-26-001491-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626001233/0001096906-26-001233-index.htm)
- 8-K · filed 2026-07-24 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626001125/0001096906-26-001125-index.htm)
- 8-K · filed 2026-06-17 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000966/0001096906-26-000966-index.htm)
- 10-Q · filed 2026-05-15 · [filing](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000803/0001096906-26-000803-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001391135.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1391135

## Cite

POPS4, Edgar & Edgarette: LFTD PARTNERS INC. (LIFD) company card, from the company's own SEC filings, accessed 2026-11-16, https://www.pops4.com/boards/company/LIFD. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

